ExtendicareEXETF +5.14%76 5-Year Yield-on-Cost % is 1.47 as of Jul. 04, 2026, which is 76% below its 10-year median of 6.22. GuruFocus rates EXETF with a GF Score™ of 76/100 and a GF Value™ of $10.00 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 282 Healthcare Providers & Services companies, Extendicare ranks worse than 71.63% on this metric.
Extendicare's yield on cost for the quarter that ended in Mar. 2026 was 1.47.
The historical rank and industry rank for Extendicare's 5-Year Yield-on-Cost % or its related term are showing as below:
EXETF'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.47 Med: 6.22 Max: 9.7
Current: 1.47
During the past 13 years, Extendicare's highest Yield on Cost was 9.70. The lowest was 1.47. And the median was 6.22.
EXETF's 5-Year Yield-on-Cost % is ranked worse than 71.63% of 282
companies
in the Healthcare Providers & Services industry
Industry Median: 2.87
vs EXETF: 1.47
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Extendicare 5-Year Yield-on-Cost % Related Terms
EXETF vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Extendicare's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Extendicare 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Extendicare's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Extendicare's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Extendicare is calculated as
Extendicare (EXETF) has a 5-Year Yield-on-Cost % of 1.47 as of Jul. 04, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Extendicare and its competitors. This is 76% below median its historical median of 6.22. Over the past decade, Extendicare's 5-Year Yield-on-Cost % has ranged from 1.47 to 9.70. According to the industry distribution chart, Extendicare ranks #202 out of 282 companies in the Healthcare Providers & Services industry, placing it in the top 71.6%.
Is Extendicare's 5-Year Yield-on-Cost % too high?
Extendicare's current 5-Year Yield-on-Cost % of 1.47 is 76% below median its 10-year median of 6.22. Over the past 10 years, this metric has ranged from a low of 1.47 to a high of 9.70. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.87. Extendicare's value of 1.47 is 48.8% below this industry median. Based on the distribution chart, Extendicare ranks #202 out of 282 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Extendicare has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Extendicare's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Extendicare ranks #202 out of 282 companies for 5-Year Yield-on-Cost %. This places Extendicare in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.87. Extendicare's value of 1.47 is 48.8% below this benchmark. Historically, Extendicare's own 5-Year Yield-on-Cost % has ranged from 1.47 to 9.70 over the past decade. While the company's 10-year median is 6.22 vs. the industry median of 2.87, Extendicare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.87, based on 282 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Extendicare's current 5-Year Yield-on-Cost % of 1.47 is 48.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Extendicare and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Extendicare's current 5-Year Yield-on-Cost % is 1.47, which is 76% below median its own 10-year median of 6.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Extendicare stock overvalued right now?
Based on GuruFocus' analysis, Extendicare (EXETF) is currently considered Significantly Overvalued. The stock's GF Value™ is $10.00, compared to a current price of $25.78 — trading 157.8% above its estimated fair value. The current 5-Year Yield-on-Cost % is 1.47, which is 76% below median its 10-year median of 6.22 and 48.8% below the Healthcare Providers & Services industry median of 2.87. Extendicare's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Extendicare (EXETF), the current 5-Year Yield-on-Cost % is 1.47 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Extendicare (EXETF) Overvalued in 2026?
Based on GuruFocus' analysis, Extendicare stock appears to be overvalued.
The current stock price of $25.78 is trading 157.8% above its estimated GF Value™ of $10.00.
GuruFocus considers Extendicare to be Significantly Overvalued.
Key valuation signals for EXETF:
5-Year Yield-on-Cost %: 1.47 (76% below median its 10-year median of 6.22)
GF Value™: $10.00 vs. price of $25.78 (157.8% above fair value)
Industry Position: 48.8% below the Healthcare Providers & Services median (#202 of 282)
No single metric tells the full story. See the EXETF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Extendicare Inc is a senior care provider in Canada, focused on long-term care and home health care. The has three main business segments: Long-term Care (LTC), Home Health Care, and Managed Services. The Long-term Care segment, operating under the Extendicare brand, represents 53 owned homes in Ontario, Alberta and Manitoba. The Home Health Care segment, operating under the ParaMed brand, provides home health care services annually in Ontario, Alberta, Manitoba and Nova Scotia. The Managed Services segment, operating under the Extendicare Assist and SGP Purchasing Partner Network brands, provides management, consulting and group purchasing services to other care providers across Canada. The majority of the company's revenue is derived from the Long-term Care segment.
76GF Score
Get the complete analysis for EXETF
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EXETF has been successfully added to your 